Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Schaeffer, Edward
Professor
Bio
My clinical and scientific focus is in prostate cancer, with an emphasis on at-risk populations, diagnosis, treatment outcomes, and the molecular biology of lethal prostate cancer. Prostate cancer is... [more]
Shenoy, Niraj
Associate Professor
Bio
The Shenoy Lab is interested in understanding and targeting the interactions between aberrant metabolism, epigenetic dysregulation, and immune evasion in cancer. While kidney cancer (clear cell r... [more]
Shilatifard, Ali
Professor
Bio
I hold the Robert Francis Furchgott Professorship and am the Chairman of the Department of Biochemistry and Molecular Genetics at Northwestern University Feinberg School of Medicine. I continue to run... [more]
Shukla, Vipul
Assistant Professor
Bio
My research broadly focuses on understanding the roles of cytosine modifications and alternative DNA structures in normal and cancer genomes. I am currently investigating the functions of G-quadruplex... [more]
Singhal, Seema
Professor
Bio
Myeloma, Transplantation
Sonabend, Adam
Associate Professor
Bio
Dr Sonabend's research focuses on Topoisomerase II-mediated transcriptional regulation in gliomas, and personalized use of TOP2- targeting chemotherapy to treat malignant brain cancer. He is also... [more]
Stupp, Roger
Professor
Bio
After completion of my clinical training in oncology/hematology,I have devoted my career to innovative treatments of cancer, with a special focus on brain tumors. While single modality... [more]
Thaxton, C. Shad
Associate Professor
Bio
The challenge of bio-nanotechnology and the focus of our lab is to control the synthesis of structures that naturally interface with biological systems to develop exquisitely targeted, practical, safe... [more]
VanderWeele, David
Associate Professor
Bio
Cancer heterogeneity and evolution with a goal of identifying and targeting drivers of cancer progression and therapy resistance. His research has described intrafocal heterogeneity in prostate cancer... [more]
Walterhouse, David O.
Professor Emeritus
Bio
As a member of the soft tissue sarcoma committee of the Children's Oncology Group (COG), my primary clinical research interest lies in the area of clinical trials for pediatric patients... [more]